FDA
approval
· 2019-12-10
FDA Approved: NEVIRAPINE — Supplemental Application (Aurobindo Pharma Limited)
Summary
The FDA approved a supplemental application for Nevirapine submitted by Aurobindo Pharma Limited (ANDA077521).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NEVIRAPINE (NEVIRAPINE)